Oric Pharmaceuticals, Inc. (ORIC) insider trading.
In Q3 2026, insiders at Oric Pharmaceuticals, Inc. reported 12 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $1.4M.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 7
- Net shares, P minus S
- -104,400
- Insiders
- 2
- Last filed
- 2026-09-29
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Piscitelli Dominic | Officer · Chief Financial Officer | 8 | 0 | 4 |
| Heyman Richard A. | Director | 4 | 0 | 3 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-28 | Piscitelli Dominic | S (D) | 13,400 | $13.53 | 69,828 | Form 4 |
| 2026-09-28 | Piscitelli Dominic | M (A) | 13,400 | $4.36 | 83,228 | Form 4 |
| 2026-09-24 | Piscitelli Dominic | M (A) | 600 | $4.36 | 70,428 | Form 4 |
| 2026-09-24 | Piscitelli Dominic | S (D) | 100 | $13.5 | 70,328 | Form 4 |
| 2026-09-24 | Piscitelli Dominic | S (D) | 500 | $13.51 | 69,828 | Form 4 |
| 2026-08-26 | Piscitelli Dominic | M (A) | 52,000 | $4.36 | 121,828 | Form 4 |
| 2026-08-26 | Piscitelli Dominic | M (A) | 25,000 | $6 | 146,828 | Form 4 |
| 2026-08-26 | Piscitelli Dominic | S (D) | 77,000 | $13.69 | 69,828 | Form 4 |
| 2026-07-24 | Heyman Richard A. | M (A) | 3,500 | $1.6 | 45,300 | Form 4 |
| 2026-07-24 | Heyman Richard A. | S (D) | 7,000 | $12.02 | 38,300 | Form 4 |
| 2026-07-24 | Heyman Richard A. | S (D) | 6,100 | $12.02 | 206,672 | Form 4 |
| 2026-07-06 | Heyman Richard A. | S (D) | 300 | $12 | 212,772 | Form 4 |
Transaction codes in this quarter
Get ORIC insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1796280&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ORIC company page · Oric Pharmaceuticals, Inc. on SEC.gov
Questions
Are insiders buying or selling Oric Pharmaceuticals, Inc. (ORIC)?
In Q3 2026, insiders at Oric Pharmaceuticals, Inc. reported 12 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 7 sales worth $1.4M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Oric Pharmaceuticals, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/oric.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.